BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28495066)

  • 1. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.
    Antonoff MB; Correa AM; Sepesi B; Nguyen QN; Walsh GL; Swisher SG; Vaporciyan AA; Mehran RJ; Hofstetter WL; Rice DC
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):689-699. PubMed ID: 28495066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
    Hearn JW; Videtic GM; Djemil T; Stephans KL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
    Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
    Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.
    Brooks ED; Sun B; Feng L; Verma V; Zhao L; Gomez DR; Liao Z; Jeter M; O'Reilly M; Welsh JW; Nguyen QN; Erasmus JJ; Eapen G; Ahrar K; Antonoff MB; Hahn SM; Heymach JV; Rice DC; Chang JY
    JAMA Netw Open; 2018 Aug; 1(4):e181390. PubMed ID: 30646121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    Yerokun BA; Yang CJ; Gulack BC; Li X; Mulvihill MS; Gu L; Wang X; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):675-686.e4. PubMed ID: 28461054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
    Torre W; Sierra A
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J; Kloecker G; Woo S; Dunlap NE
    Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
    Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
    J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.
    Kilburn JM; Lester SC; Lucas JT; Soike MH; Blackstock AW; Kearns WT; Hinson WH; Miller AA; Petty WJ; Munley MT; Urbanic JJ
    J Thorac Oncol; 2014 Apr; 9(4):572-6. PubMed ID: 24736084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer.
    Matsuo Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818798633. PubMed ID: 30198413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage Pulmonary Operations Following Stereotactic Body Radiotherapy for Small Primary and Metastatic Lung Tumors: Evaluation of the Operative Procedures.
    Hamakawa H; Takahashi Y; Sakanoue I; Saito T; Date N; Tomii K; Katakami N; Imagunbai T; Kokubo M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818807431. PubMed ID: 30415605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy.
    Hamaji M; Mitsuyoshi T; Yoshizawa A; Sato T; Matsuo Y; Chen-Yoshikawa TF; Sonobe M; Mizowaki T; Date H
    Ann Thorac Surg; 2018 Apr; 105(4):e165-e168. PubMed ID: 29571347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.
    Dworzecki T; Idasiak A; Syguła D; Dworzecka U; Suwiński R
    Neoplasma; 2012; 59(1):114-20. PubMed ID: 22103905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
    Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients.
    Chen F; Matsuo Y; Yoshizawa A; Sato T; Sakai H; Bando T; Okubo K; Shibuya K; Date H
    J Thorac Oncol; 2010 Dec; 5(12):1999-2002. PubMed ID: 21102261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.